在该公司报告损失大于预期之前,Mirum制药公司的顶尖主管出售了大量股票。 Mirum Pharmaceuticals' top executives sold substantial shares before the company reported larger-than-expected losses.

包括Jolanda Howe、Christopher Peetz和Peter Radovich在内的Mirum制药公司高级经理于3月17日出售了相当一部分公司的股票。 Senior executives of Mirum Pharmaceuticals, including Jolanda Howe, Christopher Peetz, and Peter Radovich, sold significant portions of their company stock on March 17. Howe出售了92.25%的股份, Peetz出售了16.44%,Radovich出售了一部分股份。 Howe sold 92.25% of her shares, Peetz sold 16.44%, and Radovich sold a portion of his shares. 发展稀有疾病的治疗方法的Mirum制药公司最近报告的损失比预期的要大。 Mirum Pharmaceuticals, which develops therapies for rare diseases, recently reported a larger-than-expected loss. 其铅产品LIVMARLI处理阿拉格利综合症的一个特定状况。 Its lead product, LIVMARLI, treats a specific condition in Alagille syndrome.